(Q37831269)

24 August 2017

1 reference

title

Clopidogrel and proton pump inhibitors: a clinically meaningful interaction? (English)

1 reference

24 August 2017

1 reference

Tobias Gerhard

1

1 reference

24 August 2017

publication date

17 December 2010

1 reference

Pharmacoepidemiology and Drug Safety

24 August 2017

published in

1 reference

24 August 2017

volume

20

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

214-218

1 reference

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

24 August 2017

cites work

1 reference

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

Proton pump inhibitors and clopidogrel: putting the interaction in perspective

21 January 2018

1 reference

Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?

21 January 2018

1 reference

Risk of combining PPIs with thienopyridines: fact or fiction?

21 January 2018

1 reference

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

21 January 2018

1 reference

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome

21 January 2018

1 reference

Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study

21 January 2018

1 reference

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor

21 January 2018

1 reference

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

21 January 2018

1 reference

Proton pump inhibitor and clopidogrel interaction: fact or fiction?

21 January 2018

1 reference

Drug interaction between clopidogrel and proton pump inhibitors

21 January 2018

1 reference

Proton pump inhibitors and clopidogrel: is it a significant drug interaction?

21 January 2018

1 reference

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

21 January 2018

1 reference

Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

21 January 2018

1 reference

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

21 January 2018

1 reference

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

21 January 2018

1 reference

Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study

21 January 2018

1 reference

Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes

21 January 2018

1 reference

Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study

21 January 2018

1 reference

Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention

21 January 2018

1 reference

Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study

21 January 2018

1 reference

Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study

21 January 2018

1 reference

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

21 January 2018

1 reference

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI.

21 January 2018

1 reference

Peptic disease: a confounding factor for proton pump inhibitor-clopidogrel interaction?

21 January 2018

1 reference

CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring.

21 January 2018

1 reference

Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement

21 January 2018

1 reference

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

21 January 2018

1 reference

Adverse Outcomes Associated With Use of Proton Pump Inhibitors and Clopidogrel

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.2071

1 reference

24 August 2017

1 reference